Diamond Hill Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,529
| Closed | -$1.12M | – | 154 |
|
|
2020
Q3 | $1.12M | Sell |
2,529
-491,241
| -99% | -$217M | 0.01% | 133 |
|
|
2020
Q2 | $179M | Sell |
493,770
-212,286
| -30% | -$76.9M | 1.05% | 39 |
|
|
2020
Q1 | $200M | Sell |
706,056
-11,877
| -2% | -$3.37M | 1.36% | 29 |
|
|
2019
Q4 | $233M | Sell |
717,933
-6,878
| -0.9% | -$2.23M | 1.17% | 35 |
|
|
2019
Q3 | $211M | Sell |
724,811
-2,053
| -0.3% | -$598K | 1.12% | 37 |
|
|
2019
Q2 | $213M | Sell |
726,864
-6,153
| -0.8% | -$1.81M | 1.14% | 35 |
|
|
2019
Q1 | $201M | Sell |
733,017
-18,541
| -2% | -$5.08M | 1.1% | 34 |
|
|
2018
Q4 | $168M | Sell |
751,558
-174,254
| -19% | -$39M | 0.99% | 36 |
|
|
2018
Q3 | $226M | Sell |
925,812
-172,817
| -16% | -$42.2M | 1.13% | 35 |
|
|
2018
Q2 | $228M | Buy |
1,098,629
+11,013
| +1% | +$2.28M | 1.17% | 33 |
|
|
2018
Q1 | $225M | Sell |
1,087,616
-13,411
| -1% | -$2.77M | 1.15% | 32 |
|
|
2017
Q4 | $209M | Buy |
1,101,027
+25,423
| +2% | +$4.83M | 1.05% | 38 |
|
|
2017
Q3 | $204M | Buy |
1,075,604
+360,911
| +50% | +$68.3M | 1.07% | 38 |
|
|
2017
Q2 | $125M | Buy |
714,693
+66,097
| +10% | +$11.5M | 0.67% | 54 |
|
|
2017
Q1 | $99.6M | Buy |
648,596
+1,094
| +0.2% | +$168K | 0.56% | 62 |
|
|
2016
Q4 | $91.4M | Buy |
647,502
+95,825
| +17% | +$13.5M | 0.53% | 67 |
|
|
2016
Q3 | $87.8M | Sell |
551,677
-22,388
| -4% | -$3.56M | 0.54% | 65 |
|
|
2016
Q2 | $84.8M | Sell |
574,065
-6,857
| -1% | -$1.01M | 0.54% | 62 |
|
|
2016
Q1 | $82.3M | Buy |
+580,922
| New | +$82.3M | 0.52% | 58 |
|